Duodenal Jejunal Bypass for Type 2 Diabetes (DJBD)

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

PHASE1

Total Enrollment

50 participants

Study Classification

INTERVENTIONAL

Study Start Date

2007-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Study the effect of Duodenal jejunal bypass on human adults with type 2 diabetes.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Adults non obese ( BMI less than 34 ) will undergo duodenal jejunal bypass. The Outcome measures: Blood Sugar, Insulin,HbA1c, CCK,Gastrin, GIP1and 2, Ghrelin, Cholesterol, Triglycerides,FFA, C-Peptide.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Diabetes Mellitus

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

duodenal jejunal bypass

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adults age 20-65
* Clinical diagnosis of type 2 diabetes
* Non obese with BMI less than 34.
* Oral agents or insulin to control T2DM.
* Inadequate control of diabetes as defined as HbA1c\>/7.5
* Understanding of the mechanisms of action of the treatment

Exclusion Criteria

* Children with type 1 diabetes
* Obese with BMI over 34
* Coagulopathy
* Liver cirrhosis
* Unable to comply with study requirements, follow-up or give valid consent
* Currently pregnant
* Previous upper abdominal surgery
* Inabilty to tolerate general anesthesia

Minimum Eligible Age

20 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

George S Ferzli, MD F.A.C.S

Role: PRINCIPAL_INVESTIGATOR

SUNY Downstate

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Center for Advance Medicine Abel Gonzalez

Santo Domingo, , Dominican Republic

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Dominican Republic

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

George S Ferzli, MD, F.A.C.S

Role: CONTACT

[email protected]

718-667-8100

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Abel Gonzalez, MD

Role: primary